Organigram Global Inc.

NasdaqGS:OGI Stock Report

Market Cap: US$196.5m

Organigram Global Future Growth

Future criteria checks 1/6

Organigram Global's earnings are forecast to decline at 42.8% per annum while its annual revenue is expected to grow at 13.9% per year. EPS is expected to grow by 11.1% per annum.

Key information

-42.8%

Earnings growth rate

11.06%

EPS growth rate

Pharmaceuticals earnings growth11.1%
Revenue growth rate13.9%
Future return on equityn/a
Analyst coverage

Low

Last updated20 Feb 2026

Recent future growth updates

Recent updates

Organigram Global Is Now A Strong Buy

Feb 11

Organigram Is A Small-Cap Bargain

Feb 23

Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)

Dec 22

Organigram Could Soar In 2026

Dec 01

Organigram: Why I Still Like It

Sep 15

Organigram: Q3 2024 Earnings Show Improvement In Revenues And Net Income (Hold)

Aug 14

Organigram Has Declined A Lot And Is A Great Deal

Jun 23

Organigram: Operating In A Structurally Challenged Industry

Apr 20

Don't Rule Out A Bull Market (Podcast Transcript)

Aug 02

Don't Rule Out A Bull Market

Jul 27

Organigram revenue of $38.12M beats by $12.05M, sees Q4 revenue higher than Q3

Jul 14

OrganiGram: Canadian Cannabis Remains Tough To Own

Apr 26

Why OrganiGram Should Generate Consistent Growth Going Forward

Jan 16

OrganiGram: Positive Signs, But Struggles Persist

Jul 14

Earnings and Revenue Growth Forecasts

NasdaqGS:OGI - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2028475N/AN/AN/A1
9/30/202736287223
9/30/202632514074
12/31/202528018-37-19N/A
9/30/2025259-25-25-8N/A
6/30/20252248-173N/A
3/31/202519417-27-16N/A
12/31/20246-7N/AN/AN/A
9/30/2023149-229-64-36N/A
5/31/2023161-222-80-41N/A
2/28/2023166-11-89-42N/A
11/30/2022159-8-74-23N/A
8/31/2022146-14-85-36N/A
5/31/2022125-34-63-24N/A
2/28/2022107-35-53-29N/A
11/30/202190-98-56-38N/A
8/31/202179-131-41-29N/A
5/31/202175-143-44-29N/A
2/28/202172-229-46-17N/A
11/30/202081-170-80-18N/A
8/31/202087-136-124-45N/A
5/31/202083-120-156-53N/A
2/29/202089-40-164-50N/A
11/30/201993-40N/A-47N/A
8/31/201980-10N/A-35N/A
5/31/20196731N/A-26N/A
2/28/20194645N/A-29N/A
11/30/20182253N/A-24N/A
8/31/20181222N/A-13N/A
5/31/2018112N/A-10N/A
2/28/201810-4N/A-13N/A
11/30/20176-11N/A-14N/A
8/31/20175-11N/A-9N/A
5/31/20175-8N/A-5N/A
2/28/20175-6N/A-3N/A
11/30/201670N/A0N/A
8/31/201661N/A-2N/A
5/31/201650N/A-2N/A
2/29/201630N/A-3N/A
11/30/20152-1N/A-2N/A
8/31/20151-1N/A-3N/A
5/31/20150-9N/A-2N/A
2/28/20150-10N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OGI's earnings are forecast to decline over the next 3 years (-42.8% per year).

Earnings vs Market: OGI's earnings are forecast to decline over the next 3 years (-42.8% per year).

High Growth Earnings: OGI's earnings are forecast to decline over the next 3 years.

Revenue vs Market: OGI's revenue (13.9% per year) is forecast to grow faster than the US market (10.3% per year).

High Growth Revenue: OGI's revenue (13.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if OGI's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/20 12:44
End of Day Share Price 2026/02/20 00:00
Earnings2025/12/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Organigram Global Inc. is covered by 17 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Frederico Yokota Choucair GomesATB Cormark
Jesse PytlakATB Cormark Historical (Cormark Securities)